Chemoinformaics analysis of Panaxydol chlorohydrin
| Molecular Weight | 296.838 | nRot | 9 |
| Heavy Atom Molecular Weight | 271.638 | nRig | 15 |
| Exact Molecular Weight | 296.154 | nRing | 0 |
| Solubility: LogS | -5.098 | nHRing | 0 |
| Solubility: LogP | 4.173 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 48.8438 |
| nHD | 2 | BPOL | 25.5902 |
| QED | 0.568 |
| Synth | 5.209 |
| Natural Product Likeliness | 3.247 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.048 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.744 |
| MDCK | 0.0000247 |
| BBB | 0.795 |
| PPB | 0.881515 |
| VDSS | 1.552 |
| FU | 0.103553 |
| CYP1A2-inh | 0.131 |
| CYP1A2-sub | 0.495 |
| CYP2c19-inh | 0.192 |
| CYP2c19-sub | 0.927 |
| CYP2c9-inh | 0.35 |
| CYP2c9-sub | 0.261 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.771 |
| CYP3a4-inh | 0.161 |
| CYP3a4-sub | 0.437 |
| CL | 19.778 |
| T12 | 0.058 |
| hERG | 0.02 |
| Ames | 0.025 |
| ROA | 0.441 |
| SkinSen | 0.662 |
| Carcinogencity | 0.04 |
| EI | 0.243 |
| Respiratory | 0.939 |
| NR-Aromatase | 0.289 |
| Antiviral | Yes |
| Prediction | 0.79548 |